Drugs / haplo-identical cells (donor)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02508324 | Sep 2015 → Jun 2022 | acute myeloid leukemia, myelodysplastic syndrome | Weill Medical College of Cornell University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | haplo-identical cells (donor) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02508324 ↗ |
| Modality | Cell therapy | “Adoptive immunotherapy means using an infusion of cells from a donor to help fight cancer.” NCT02508324 ↗ |